Cas:606104-92-1 1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea manufacturer & supplier

Chemical Name:1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea

CAS.NO:606104-92-1

Synonyms:1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea

Molecular Formula:C₂₁H₂₁N₅O

Molecular Weight:359.42400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:99.26000

Exact Mass:359.17500

LogP:3.34338

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea Use and application,1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea technical grade,usp/ep/jp grade.

Related News: ��We believe such actions are our last resort,�� the Hospital Authority Employees Alliance, a union that formed during the city��s antigovernment protest movement, wrote in a statement. 1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea manufacturer The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. 1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea supplier A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. 1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea vendor There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space. 1-benzyl-1-[2-[(3-cyano-8-methylquinolin-2-yl)amino]ethyl]urea factory The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774.